Insider Ledger
Maxcyte, Inc. (MXCT) insider buying and SEC filings
Maxcyte, Inc. · CIK 1287098
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Services-Commercial Physical & Biological Research
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- MAXCYTE INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$8K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 17, 2026 | Sale | Douglas J Swirsky (CFO) sold 10,142 shares at about $0.8200 ($8K). Holdings down 6% to 151,669 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MXCT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.